You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

Guidelines & Advice

About Guidelines Email Guidelines Team

Displaying Guidelines

229 Items

An Endorsement of the 2023 International Stereotactic Radiosurgery Society’s (ISRS) Guideline: A Systematic Review Informing the Management of Symptomatic Brain Radiation Necrosis After Stereotactic Radiosurgery and ISRS Recommendations

Document Status: Current
ID: Guideline Endorsement C50-CIDAP-3

Updated

Mar 2025

An Endorsement of the ASCO-SNO Guideline on Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults

Document Status: Current
ID: GL END 9-10
Version: 2

Aug 2022

An Endorsement of the ASTRO/ESTRO 2023 Guideline for the Treatment of Patients with Oligometastatic or Oligoprogressive Non-Small Cell Lung Cancer

Document Status: Current
ID: GL END 7-24

Nov 2024

Approach to Fever Assessment in Ambulatory Cancer Patients Receiving Chemotherapy

Document Status: Current
ID: 12-15

Dec 2015

Autologous hematopoietic cell transplantation for autoimmune diseases

Document Status: Current
ID: ES SCT-10

May 2019

Baseline Staging Imaging for Distant Metastasis in Women with Stage I, II, and III Breast Cancer

Document Status: Current
ID: GL 1-14
Version: 3

Oct 2019

Best Practice Guidance for Patient-Specific Quality Assurance for IMRT and VMAT Plan Delivery Verification

Document Status: Current

Oct 2019

Best-Practice Guidance for Radiation Treatment Plan Physics Review

Document Status: Current

Apr 2020

Best Practice Recommendations for Regimen Development and Maintenance

Document Status: Current
ID: GL-C50-25

Feb 2016

Bowel Preparation Selection Best Practice Guidelines

Document Status: Current

Jun 2021

Cancer and the Health Effects of Cannabis and Cannabinoids: An update of the systematic review by the National Academies of Sciences, Engineering, and Medicine (2017) Consensus Study Report

Document Status: Current
ID: ES 23-2
Version: N/A

Jun 2020

Cancer Care Ontario Beyond-Use Date Recommendations Report

Document Status: Current
ID: N/A
Version: 1

Mar 2018